Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour load

It was recently demonstrated that IL-8 is produced by melanoma cell lines and acts as an essential autocrine growth factor. We studied the constitutive production of IL-8 by melanoma cell lines and the serum concentrations in patients with metastatic melanoma. All of 10 melanoma cell lines investiga...

Full description

Saved in:
Bibliographic Details
Main Authors: Scheibenbogen, Carmen (Author) , Möhler, Thomas (Author) , Haefele, Joachim (Author) , Hunstein, Werner (Author) , Keilholz, Ulrich (Author)
Format: Article (Journal)
Language:English
Published: June 1995
In: Melanoma research
Year: 1995, Volume: 5, Issue: 3, Pages: 179-182
ISSN:1473-5636
DOI:10.1097/00008390-199506000-00006
Online Access:Verlag: https://doi.org/10.1097/00008390-199506000-00006
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/melanomaresearch/abstract/1995/06000/serum_interleukin_8__il_8__is_elevated_in_patients.6.aspx
Get full text
Author Notes:C. Scheibenbogen, T. Möhler, J. Haefele, W. Hunstein, U. Keilholz
Description
Summary:It was recently demonstrated that IL-8 is produced by melanoma cell lines and acts as an essential autocrine growth factor. We studied the constitutive production of IL-8 by melanoma cell lines and the serum concentrations in patients with metastatic melanoma. All of 10 melanoma cell lines investigated constitutively produced IL-8 (mean 315 ± 58 pg/10s cells per 24 h. IL-8 was detectable (mean 159 ± 13.1 pg/ml) in the serum of 21 out of 56 patients by an enzyme-linked immunosorbent assay (ELISA; detection limit < 100 pg/ml). There was a significant correlation with tumour load, whereas no correlation with metastatic sites was found. No increased IL-8 levels were seen in healthy controls or patients with metastatic renal cell carcinoma. These results suggest that IL-8 is constitutively produced by melanoma cells in vivo.
Item Description:Gesehen am 27.11.2025
Physical Description:Online Resource
ISSN:1473-5636
DOI:10.1097/00008390-199506000-00006